Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedMar 27, 2023
DataAggregated Company Financials
Companies50
  • 7D2.4%
  • 3M1.5%
  • 1Y-5.2%
  • YTD3.2%

In the last week, the Biotech industry is up 2.4%, with TaiMed Biologics up 31%. However, the industry is down 5.2% over the past year. Looking forward, earnings are forecast to grow by 101% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Mar 2023NT$504.9bNT$20.5b-NT$9,016,573,000.0037.3x-56x24.7x
Wed, 22 Feb 2023NT$524.4bNT$21.8b-NT$7,840,926,000.0038x-66.9x24x
Fri, 20 Jan 2023NT$494.2bNT$21.8b-NT$7,778,690,000.0036.2x-63.5x22.7x
Sun, 18 Dec 2022NT$512.6bNT$21.8b-NT$7,522,211,000.0037.1x-68.1x23.5x
Tue, 15 Nov 2022NT$495.2bNT$23.1b-NT$6,774,948,000.0033.1x-73.1x21.5x
Thu, 13 Oct 2022NT$480.5bNT$23.1b-NT$6,633,590,000.0035x-72.4x20.8x
Sat, 10 Sep 2022NT$630.6bNT$23.1b-NT$6,633,590,000.0044.6x-95.1x27.3x
Mon, 08 Aug 2022NT$560.6bNT$22.6b-NT$5,727,813,000.0032.8x-97.9x24.9x
Wed, 06 Jul 2022NT$502.4bNT$22.5b-NT$5,642,821,000.0029.9x-89x22.3x
Fri, 03 Jun 2022NT$506.4bNT$22.5b-NT$5,642,821,000.0031.9x-89.7x22.5x
Sun, 01 May 2022NT$529.2bNT$21.4b-NT$5,787,788,000.0044.4x-91.4x24.7x
Tue, 29 Mar 2022NT$518.3bNT$19.6b-NT$5,068,875,000.0028.6x-102.3x26.5x
Thu, 24 Feb 2022NT$474.3bNT$17.9b-NT$5,564,340,000.0024.9x-85.2x26.5x
Sat, 22 Jan 2022NT$428.1bNT$17.9b-NT$5,532,702,000.0024.3x-77.4x23.9x
Mon, 20 Dec 2021NT$462.4bNT$17.9b-NT$5,579,296,000.0026.5x-82.9x25.8x
Wed, 17 Nov 2021NT$354.7bNT$16.9b-NT$6,474,311,000.0022x-54.8x20.9x
Fri, 15 Oct 2021NT$341.8bNT$15.4b-NT$7,624,179,000.0019.6x-44.8x22.2x
Sun, 12 Sep 2021NT$385.5bNT$15.4b-NT$7,624,179,000.0022x-50.6x25.1x
Tue, 10 Aug 2021NT$395.1bNT$15.4b-NT$7,624,179,000.0021.1x-51.8x25.7x
Mon, 03 May 2021NT$403.0bNT$13.7b-NT$8,453,670,500.0026.8x-47.7x29.3x
Thu, 04 Feb 2021NT$272.0bNT$13.4b-NT$8,436,837,000.0023.8x-32.2x20.4x
Sun, 08 Nov 2020NT$275.1bNT$11.8b-NT$10,319,873,500.0078.3x-26.7x23.3x
Sat, 01 Aug 2020NT$290.5bNT$11.2b-NT$10,631,308,000.0051.2x-27.3x25.9x
Tue, 05 May 2020NT$194.0bNT$10.8b-NT$10,916,068,500.0061.2x-17.8x18x
Price to Earnings Ratio

-14.4x


Total Market Cap: NT$157.2bTotal Earnings: -NT$10,916,068,500.00Total Revenue: NT$10.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -56.6x202120222023
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 24.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market3.01%
Healthcare3.04%
Biotech2.45%
Biotech2.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4147 TaiMed BiologicsNT$95.7031.1%
+NT$5.7b		50.9%PS42.9x
6550 Polaris GroupNT$97.806.0%
+NT$4.1b		-16.1%PS6575.7x
6733 BioGend TherapeuticsNT$34.0035.5%
+NT$1.6b		37.1%PS165.7x
4162 PharmaEngineNT$113.007.6%
+NT$1.1b		16.5%PE50.9x
6541 Tanvex BioPharmaNT$91.9010.7%
+NT$1.0b		-44.5%PS482.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate Program
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4157

NT$15.65

TaiGen Biopharmaceuticals Holdings

7D

9.8%

1Y

-11.8%

4147

NT$95.70

TaiMed Biologics

7D

31.1%

1Y

50.9%

4162

NT$113.00

PharmaEngine

7D

7.6%

1Y

16.5%

4174

NT$81.90

OBI Pharma

7D

5.0%

1Y

-25.5%

6645

NT$35.10

Kim Forest Enterprise

7D

-6.1%

1Y

28.0%

6446

NT$439.50

PharmaEssentia

7D

-2.5%

1Y

37.6%

4194

NT$38.70

Holy Stone Healthcare

7D

-4.3%

1Y

69.0%

6550

NT$97.80

Polaris Group

7D

6.0%

1Y

-16.1%

6541

NT$91.90

Tanvex BioPharma

7D

10.7%

1Y

-44.5%

7427

NT$80.70

Great Novel Therapeutics Biotech & Medicals

7D

-3.1%

1Y

104.3%

6875

NT$80.30

Pharmosa Biopharm

7D

-2.9%

1Y

106.2%

6733

NT$34.00

BioGend Therapeutics

7D

35.5%

1Y

37.1%

6712

NT$214.00

Ever Supreme Bio Technology

7D

5.9%

1Y

24.6%

6580

NT$33.95

TaiRx

7D

-2.9%

1Y

-12.6%

6617

NT$309.50

Gongwin Biopharm Holdings

7D

-1.6%

1Y

24.0%

6549

NT$32.05

TaiwanJ Pharmaceuticals

7D

-10.2%

1Y

173.9%

Companies Like TaiwanJ Pharmaceuticals (GTSM:6549) Are In A Position To Invest In Growth

Apr 14
Companies Like TaiwanJ Pharmaceuticals (GTSM:6549) Are In A Position To Invest In Growth